Ketamine for Mental Health: Effectiveness and Options

For people living with depression that hasn’t responded to traditional treatment, the frustration can be overwhelming. Standard antidepressants don’t work for everyone—and even when they do, relief can take weeks or longer. Ketamine therapy offers a fundamentally different approach, acting on a separate brain pathway that may deliver improvement far more quickly.

Rather than targeting serotonin like most antidepressants, ketamine works through the brain’s glutamate system. This mechanism is believed to support neural connectivity and restore communication between brain regions involved in mood regulation. For some patients, this translates into noticeable symptom relief within hours or days instead of weeks.

The FDA approval of Spravato® (esketamine nasal spray) marked a major step forward in making ketamine-based treatment more accessible. It provides a regulated, evidence-based option for individuals with treatment-resistant depression who have not found adequate relief with conventional medications.

Below, we’ll break down how ketamine therapy works, who may benefit, what treatment looks like in practice, and how insurance coverage factors into choosing the right care setting.

Key Takeaways

• Rapid-acting relief: Ketamine therapy is known for its fast onset, with many patients reporting improvement within hours or days rather than weeks.

• Different mechanism of action: Instead of serotonin, ketamine targets glutamate pathways involved in neuroplasticity and mood regulation.

• Spravato® is FDA-approved: Esketamine nasal spray has been clinically studied, FDA-approved for treatment-resistant depression, and is often covered by insurance.

• Coverage varies by treatment type: Spravato® is typically insurance-covered, while IV ketamine infusions are usually self-pay.

• Defined eligibility criteria: Many patients qualify after trying at least two antidepressants for an adequate duration without meaningful improvement.

• Evidence-based use: Spravato® is currently approved for treatment-resistant depression and major depressive disorder with suicidality; research into other conditions is ongoing.

• Clinical setting matters: Treatment should always be delivered in a medically supervised, supportive environment with experienced providers.

• Getting started is structured: The process generally includes eligibility screening, insurance verification, provider consultation, and a coordinated care plan.

What Is Ketamine Therapy for Mental Health?

Ketamine therapy is a medically supervised treatment used to help individuals with depression that hasn’t responded to traditional approaches. It involves administering carefully controlled doses of ketamine in a clinical setting, where patients are monitored for both safety and comfort throughout the session.

Although ketamine has been used in medicine for decades as an anesthetic, its role in mental health treatment is relatively recent. In 2019, the FDA approved esketamine nasal spray (Spravato®) specifically for treatment-resistant depression, recognizing its effectiveness for patients who had not improved with standard antidepressants.

What makes ketamine therapy different is how it works in the brain. Rather than acting on serotonin like most antidepressants, ketamine targets the glutamate system—an entirely different pathway involved in mood regulation. Because of this mechanism, some patients experience relief much faster, sometimes within hours or days instead of weeks.

How Ketamine Therapy Works

Ketamine works by blocking NMDA receptors within the brain’s glutamate system. This action leads to an increase in glutamate signaling, which sets off a series of neurochemical changes associated with improved mood and cognitive flexibility.

One of the most important effects of ketamine is its impact on neuroplasticity—the brain’s ability to form and strengthen new neural connections. These changes may help disrupt rigid, negative thought patterns and support healthier emotional processing.

Unlike traditional antidepressants that require gradual chemical buildup over time, ketamine’s effects occur through more immediate changes in brain signaling. This is why it can be especially helpful for individuals experiencing severe or persistent depressive symptoms.

Who May Benefit From Ketamine Treatment

Ketamine therapy is most commonly considered for individuals with treatment-resistant depression, meaning they have tried at least two different antidepressant medications—each for an adequate duration—without meaningful improvement.

Spravato® is FDA-approved for:

• Adults with treatment-resistant depression, and

• Adults with major depressive disorder accompanied by suicidal thoughts, where rapid symptom relief may be critical

Before beginning treatment, patients undergo a thorough medical and mental health evaluation. This includes a review of medical history, current medications, and overall health to determine whether ketamine therapy is appropriate and safe.

Certain conditions may make ketamine treatment unsuitable, such as uncontrolled high blood pressure, active psychosis, or ongoing substance misuse. A proper clinical assessment helps ensure that treatment decisions are made carefully and responsibly.

Are There Side Effects — or Does Ketamine Therapy Make You “High”?

Ketamine therapy can cause temporary side effects, but these effects are expected, short-lived, and closely monitored in a clinical setting. The experience is very different from recreational use, both in dose and in purpose.

Some patients notice mild dissociation during treatment. This can feel like a sense of detachment from surroundings, time distortion, or dream-like sensations. While unfamiliar at first, this response is a known part of how ketamine influences brain connectivity and supports changes in mood-related neural pathways.

Common Temporary Side Effects May Include:

• Floating or light dissociation: A sense of mental or physical detachment

• Mild nausea: Often preventable or manageable with medication

• Changes in blood pressure: Continuously monitored during treatment

• Drowsiness or fatigue: Many patients feel tired afterward

  
  

These effects typically fade within one to two hours after the session ends. The doses used for mental health treatment are significantly lower than anesthetic doses and are administered under medical supervision. Patients do not experience the uncontrolled or intense “high” associated with recreational ketamine use.

At Fuse, every session is supervised by trained medical professionals who monitor vital signs and patient comfort throughout the visit. The goal is therapeutic benefit—not sedation, escape, or intoxication—and safety is central to the treatment process.

Choosing the Right Setting for Ketamine Mental Health Treatment

The environment where ketamine therapy is delivered plays an important role in both comfort and overall experience. Because this treatment can involve perceptual changes and heightened awareness, a calm, professional setting helps patients feel safe, supported, and at ease throughout their visit.

When evaluating a ketamine clinic, it’s important to look beyond the treatment itself and consider the standards of care that surround it.

Key Features to Look for in a Quality Ketamine Clinic

• Qualified medical oversight: Treatment should be supervised by licensed medical professionals with experience in mental health and ketamine-based care

• Safety protocols and preparedness: Clinics should be fully equipped to monitor vital signs and respond appropriately to any unexpected reactions

• Comfort-focused spaces: A quiet, relaxing environment can help reduce anxiety and support a more positive treatment experience

• Confidential, respectful care: Privacy and discretion are essential for mental health treatment

At Fuse Mind & Body, ketamine therapy is delivered in a carefully designed clinical setting that balances medical rigor with patient comfort. From the treatment room to ongoing support, every element is structured to provide safe, thoughtful care for individuals seeking relief from treatment-resistant depression.

Moving Forward With Thoughtful, Compassionate Care

For individuals who haven’t experienced meaningful improvement with traditional antidepressants, ketamine therapy represents a different path forward. Its rapid action and distinct mechanism offer a potential option when standard treatments haven’t delivered the relief needed.

Equally important is how and where that care is provided. Ketamine therapy should always be administered under professional medical supervision, in an environment that prioritizes both safety and patient well-being. When delivered responsibly, this approach allows therapeutic benefits to be maximized while risks remain carefully managed.

If you’re considering ketamine therapy, the next step is a personalized evaluation. A consultation allows you to discuss your history, goals, and eligibility, and to determine whether this treatment approach aligns with your needs.